INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 71 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $758,000 | +62.3% | 82,422 | +108.0% | 0.19% | +61.5% |
| Q3 2016 | $467,000 | -9.0% | 39,624 | 0.0% | 0.12% | -17.0% |
| Q2 2016 | $513,000 | -19.1% | 39,624 | -0.0% | 0.14% | -17.1% |
| Q1 2016 | $634,000 | -44.1% | 39,640 | 0.0% | 0.17% | -43.9% |
| Q4 2015 | $1,135,000 | +113400.0% | 39,640 | +99000.0% | 0.30% | – |
| Q3 2015 | $1,000 | -50.0% | 40 | -20.0% | 0.00% | – |
| Q2 2015 | $2,000 | 0.0% | 50 | +47.1% | 0.00% | – |
| Q1 2015 | $2,000 | 0.0% | 34 | -12.8% | 0.00% | – |
| Q4 2014 | $2,000 | -33.3% | 39 | -55.7% | 0.00% | – |
| Q3 2014 | $3,000 | -25.0% | 88 | -45.0% | 0.00% | – |
| Q2 2014 | $4,000 | -20.0% | 160 | +15.1% | 0.00% | -100.0% |
| Q1 2014 | $5,000 | -16.7% | 139 | -18.2% | 0.00% | 0.0% |
| Q4 2013 | $6,000 | +20.0% | 170 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $5,000 | – | 170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 8,912,072 | $142,504,000 | 2.66% |
| Antipodean Advisors LLC | 342,294 | $5,473,000 | 2.48% |
| JW Asset Management, LLC | 221,538 | $3,542,000 | 2.31% |
| Parametrica Management Ltd | 33,562 | $537,000 | 1.92% |
| 12 West Capital Management LP | 623,791 | $9,974,000 | 1.39% |
| Folger Hill Asset Management LP | 1,418,138 | $22,676,000 | 1.27% |
| Bellevue Group AG | 281,000 | $4,493,000 | 0.82% |
| Plymouth Lane Capital Management, LLC | 55,300 | $884,000 | 0.78% |
| Orbimed Advisors | 4,557,740 | $72,878,000 | 0.77% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 79,550 | $1,272,000 | 0.60% |